Advances in siRNA Developing Delivery Solutions

In today's featured interview from TIDES 2014, Jared A. Gollob, M.D., Vice President, Clinical Research, Alnylam Pharmaceuticals, Inc. discusses exciting advances in siRNA.  He says there are several different delivery formulations and the company goes after targets they have confidence in.  He also talks about focusing on moving siRNA therapies into Phase III trials.  To learn more, watch the interview:


TIDES 2015 will take place May 3-6, 2015 in San Diego, California.  This year,John Maraganore, Ph.D.; Chief Executive Officer, Alnylam Pharmaceuticals, will be giving the keynote presentation Strategies and Challenges in the Development of Oligonucleotide and Peptide Drugs: Perspectives on DrugDevice Combinations and Drug Product.  For more information about this session and the rest of the program, download the agenda.  As a reader of this blog, when you register to join us and mention code XB15180BLOG, you can save 20% off standard rates.

Share this article with your social network, just click below to share now!

Share |